| MR编号 | SE/H/1720/001 |
|---|
| 药品名称 | Finomel Perifer |
|---|
| 活性成分 | - isoleucine 6.0 g/l
- lysine 5.8 g/l
- phenylalanine 5.6 g/l
- potassium chloride acetate 4.48 g/l
- tyrosine 0.4 g/l
- valine 5.8 g/l
- arginine 11.5 g/l
- alanine 20.7 g/l
- histidine 4.8 g/l
- zinc sulfate 0.02 g/l
- soybean oil 60.0 g/l
- sodium glycerophosphate hydrate 5.92 g/l
- sodium acetate 5.62 g/l
- serine 5.0 g/l
- proline 6.8 g/l
- methionine 4.0 g/l
- medium-chain triglycerides 50.0 g/l
- MAGNESIUMSULFAT 2.47 g/l
- leucine 7.3 g/l
- glucose 130.0 g/l
- fish oil, rich in omega 3-acids 40.0 g/l
- CALCIUMCHLORID dihydrate 0.74 g/l
- threonine 4.2 g/l
- olive oil 50.0 g/l
- tryptophan 1.8 g/l
- glycine 10.3 g/l
|
|---|
| 剂型 | Emulsion for infusion |
|---|
| 上市许可持有人 | Baxter Medical AB
Sweden |
|---|
| 参考成员国 - 产品名称 | Sweden (SE) |
|---|
| 互认成员国 - 产品名称 | - Austria (AT)
Finomel Peri Emulsion zur Infusion - France (FR)
- Spain (ES)
- Italy (IT)
- Greece (GR)
- Norway (NO)
Finomel Perifer - Finland (FI)
- Poland (PL)
Finomel Peri - Czechia (CZ)
FINOMEL, infuzní emulze - Germany (DE)
Finomel - Denmark (DK)
- Belgium (BE)
Periomegomel émulsion pour perfusion - Netherlands (NL)
Finomel Peri, Finomel - Luxembourg (LU)
Periomegomel, Emulsion pour perfusion - Iceland (IS)
Finomel Perifer innrennslislyf, fleyti - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
|
|---|
| 许可日期 | 2018/11/28 |
|---|
| 最近更新日期 | 2023/12/29 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|